A. A. Timofeeva

A. A. Timofeeva

Auto-generated profile, based on publicly available information

A. A. Timofeeva

Sechenov First Moscow State Medical University (Sechenov University)

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2021 in Russian Journal of Gastroenterology, Hepatology, Coloproctology
Verified
Journal Article
Open access
PDF file
ATA. A. Timofeeva
A. A. Timofeeva
YSYu. O. Shulpekova
Yu. O. Shulpekova
VNVladimir Nechaev
Vladimir Nechaev
MSM. R. Skhirtladze
M. R. Skhirtladze
Aim. The clinical observation highlights plausible compound origins of diarrhoea, fever and neutrophilic leucocytosis in COVID-19 and the rationale to exclude Clostridium difficile infection in such patients.Key points. A 57-yo female patient was admitted in May 2020 with the complaints of 39 °C fever, general weakness, polymyalgia, diarrhoea to 3–4 times a day (mushy stool, no morbid inclusions). Initial diarrhoea was non-severe and likely triggered by the coronavirus infection. A background antibiotic and putative-immunosuppressive therapy proceeded with watery diarrhoea to 7–8 times a day and C. difficile toxins A and B detected in stool. The C. difficile infection relapsed on day 10 of vancomycin withdrawal and associated with elevated body temperature, diarrhoea and neutrophil leucocytosis; signs of colitis determined in ultrasound and CT. Exacerbation was successfully treated in a repeated metronidazole-combined vancomycin course.Conclusion. Patients with COVID-19 are at risk of clostridial colitis due to massive antibiotic, systemic glucocorticoid and biologics-based therapy they receive. The opportunistic bacterial infection of C. difficile often proceeds undetected due to its potential mirroring of COVID-19 presentation. A screening algorithm in COVID-19 patients with diarrhoea should imply steps for C. difficile detection.

31 December 2020 in Russian Journal of Gastroenterology, Hepatology, Coloproctology
Verified
Journal Article
Open access
PDF file
MSM. R. Skhirtladze
M. R. Skhirtladze
ATA. A. Timofeeva
A. A. Timofeeva
EBE. L. Bueverova
E. L. Bueverova
MAM. N. Aladin
M. N. Aladin
RRR. T. Rzayev
R. T. Rzayev
Боль в животе как первое проявление новой коронавирусной инфекции COVID-19

30 December 2018 in Clinical Medicine (Russian Journal)
Verified
Journal Article
Open access
AKA. A. Krutova
A. A. Krutova
IBI. M. Borovkov
I. M. Borovkov
MSM. R. Skhirtladze
M. R. Skhirtladze
VZV. N. Zozulya
V. N. Zozulya